Pfizer, BioNTech Seek To Nix Moderna Vax IP Suit, Countersue
Several Moderna patents related to technology behind the mRNA platform in COVID-19 vaccines are invalid, rival vaccine-makers Pfizer Inc. and BioNTech told a Massachusetts federal judge on Monday in a bid...To view the full article, register now.
Already a subscriber? Click here to view full article